申请人:YAMANOUCHI PHARMACEUTICAL CO. LTD.
公开号:EP0696585A1
公开(公告)日:1996-02-14
A bisoxadiazolidinedione derivative of general formula (I) useful as an insulin-sensitivity improver, a pharmaceutically acceptable salt thereof, and a medicinal composition thereof, wherein (a) and (b) may be the same or different from each other and each represent an optionally substituted phenylene group, and L represents: (1) an oxygen atom, (2) a group of formula (II) (R¹ being a hydrogen atom or a lower alkyl group), (3) a group of the formula: -S(O)n- (n being 0, 1 or 2), (4) a group of the formula: -CO-, (5) a group of formula (III) or (IV) (R² being a hydrogen atom or a lower alkyl group), or (6) an alkylene or alkenylene group which may be substituted and interrupted by an oxygen atom and/or a sulfur atom, and the like.
一种用作胰岛素敏感性改善剂的通式(I)的双噁二唑烷二酮衍生物、其药学上可接受的盐及其药物组合物,其中(a)和(b)可以相同或互不相同,且各自代表任选取代的亚苯基,L代表:(1) 氧原子,(2) 式 (II) 的基团(R¹ 为氢原子或低级烷基),(3) 式中的基团:-S(O)n-(n 为 0、1 或 2),(4) 式中的一个基团:-CO-,(5)式(III)或(IV)的基团(R²为氢原子或低级烷基),或(6)可被氧原子和/或硫原子取代和间断的亚烷基或烯基等。